Chunyang Zhan

Hainan Institute of Biotechnology, Haikou, 570206, Hainan, China
Author    Correspondence author
GMO Biosafety Research, 2024, Vol. 15, No. 1   
Received: 17 Dec., 2023    Accepted: 24 Jan., 2024    Published: 06 Feb., 2024

This is an open access article published under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Synthetic biology is a rapidly evolving field that merges biology and engineering to create novel biological systems and applications. This study explores the intersection of synthetic biology innovations and intellectual property (IP) rights, focusing on the future balance and coordination necessary to foster responsible innovation. The study synthesizes insights from various studies, highlighting the importance of collaborative frameworks, such as the Synthetic Biology Open Language (SBOL), and the challenges posed by patent disputes and IP rights. It also discusses the potential of synthetic biology to revolutionize fields like medicine, energy, and environmental sustainability, while emphasizing the need for a robust governance structure to address ethical, legal, and societal implications. The study concludes with recommendations for policymakers and researchers to navigate the complex IP landscape, ensuring that synthetic biology can achieve its full potential in a responsible and inclusive manner.

Synthetic biology; Intellectual property; Responsible innovation; Patent disputes; Governance structure